Fundraising FoxVida Ventures — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.
BiotechDeep TechHealthtechBoston, US
Steve Petrou(Co-Founder, President of Research & Development)inKiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in
BoardNicholas G. Galakatos(Director)in
Board seatStefan Vitorovic· per SEC Form D
Co-investorsAvoro Capital AdvisorsCapria VenturesOCV PartnersAlameda ResearchAPOLLO PROJECTSBlackstone+6 more
AskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease.
BiotechDeep TechHealthtechDurham, US
Sheila Mikhail(CEO, Treasurer and Secretary)inRichard Samulski(President and Chief Science Officer)Katherine Wood(Director)Fred Cohen(Director)Javier Garcia(Director)John Schilling(Director)
Co-investorsColumbus Venture PartnersTPG
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardWilliam J Link(Director)Ali Behbahani(Director)in
Co-investorsFlying L PartnersNew Enterprise Associates (NEA)Versant Venture AIV HoldingsVersant Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.